← All trials
NCT02151604
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 23, 2014
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- May 30, 2014
- Last posted
- Feb 23, 2023
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OxfordLead sponsor
- National Institute for Health Research, United KingdomCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.